Download FREE Report Sample
Download Free sampleTreatment for chronic hepatitis B may include: Antiviral medications. Several antiviral medications ? including entecavir (Baraclude),?tenofovir?(Viread),?lamivudine?(Epivir), adefovir (Hepsera) and telbivudine (Tyzeka) ? can help fight the virus and slow its ability to damage your liver.
Hepatitis B Therapeutic Drug Market contains market size and forecasts of Hepatitis B Therapeutic Drug in Global, including the following market information:
Global Hepatitis B Therapeutic Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hepatitis B Therapeutic Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Entecavir Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis B Therapeutic Drug include GlaxoSmithKline, Bristol-Myers Squibb, Mitsubishi Tanabe Pharma, Johnson & Johnson, Roche, Gilead Sciences, Merck & Co. Inc., Novartis and AbbVie. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis B Therapeutic Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B Therapeutic Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis B Therapeutic Drug Market Segment Percentages, by Type, 2021 (%)
Entecavir
Tenofovir
Lamivudine
Adefovir
Telbivudine
Others
Global Hepatitis B Therapeutic Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis B Therapeutic Drug Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies & Drug Stores
Others
Global Hepatitis B Therapeutic Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hepatitis B Therapeutic Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B Therapeutic Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hepatitis B Therapeutic Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Bristol-Myers Squibb
Mitsubishi Tanabe Pharma
Johnson & Johnson
Roche
Gilead Sciences
Merck & Co. Inc.
Novartis
AbbVie
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
